A Multi-Center, Flexible Dose Study With A Double-Blind, Randomized, Placebo-Controlled Phase Followed By An Open-Label Phase To Evaluate The Impact Of Treatment With Sildenafil Citrate On The Symptoms Of Depression And Quality Of Life (Qol) Of Male Patients With Erectile Dysfunction (ED)
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Sildenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Pfizer
- 29 Oct 2006 New trial record.